Primary cell model for activation-inducible human immunodeficiency virus - Wikidata - wikimedia - TriplyDB

Primary cell model for activation-inducible human immunodeficiency virus

Primary cell model for activation-inducible human immunodeficiency virus

http://www.wikidata.org/entity/Q42093067

about

Recent developments in human immunodeficiency virus-1 latency research Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells HIV persistence: chemokines and their signalling pathways.Combinatorial latency reactivation for HIV-1 subtypes and variants Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1 A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.Towards an HIV cure: a global scientific strategy Disruption of Type I Interferon Induction by HIV Infection of T Cells.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication HIV reservoirs and latency models.High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.Eradication of HIV: current challenges and new directions.HDAC inhibitors in HIV.Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Finding a cure for human immunodeficiency virus-1 infection.HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes.LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction.Establishment and maintenance of HIV latency: model systems and opportunities for intervention.HIV latency in the humanized BLT mouse.The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophages.

P2860

Q27013114-92E118CC-4D28-4E67-86BB-2E88CB5655B5 Q28728736-C19BC46C-83D9-4FA7-91F7-F0F9EDE1A1F7 Q33508788-48729435-1EB7-430F-8505-01BDEFFB5334 Q33549606-E71153DF-D473-4F92-8624-F3E809F6D6CE Q33774665-8E4F1FFA-12CC-4DCC-B68E-405DCA49AA49 Q33877492-11299340-950D-4BFE-BB62-98EA15DF11A7 Q34132738-4E0C80B3-0D5E-4F17-A6C8-94C78FC8F1DD Q34145909-65B5EECD-0806-4A76-8FF5-1D795B307DAD Q34544409-30C60B92-870C-4846-991A-E116F6CB9ED2 Q34640562-FDFF6EC5-2DDE-4138-B1BF-A4335F4D4F92 Q35777137-9F8E4401-F50C-46C3-B85F-045BFA78C570 Q36330062-E0775D91-F4FD-4363-9FEC-6A2765ABBB88 Q36746403-CEF5D135-C981-42F5-98B8-E839334F62F4 Q37123276-4D90CA1C-E718-4270-B2EE-2B3F86BF8C48 Q37317698-52DD51A9-2392-4686-A724-9B595C6F4520 Q37956178-08D74085-0AFA-436A-AA54-E318B167F542 Q38078562-236F855C-DBBB-4E9E-90C4-DD9B7AA112FC Q38256237-CECDDB81-C964-442B-B1ED-8E749E113A3D Q38270498-82A2029D-7D03-4778-946D-6B8E56DA282E Q38808202-C204B370-CFDD-481D-8194-8802EACCCE92 Q39712159-430880CA-19C3-4FFA-934C-CB2F9AFD1740 Q39783316-1A31BC25-B108-451C-B5C2-965FCAE5E77C Q40321405-F3C8BE94-AC63-42A1-92F6-A0D6922A68CC Q41954397-07153121-1093-4852-AAA5-2CD9D1230988 Q42849831-951A3C61-E4DD-43A1-83CD-ECDEDC5C4300

P2860

Primary cell model for activation-inducible human immunodeficiency virus

http://www.wikidata.org/entity/Q42093067

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Primary cell model for activation-inducible human immunodeficiency virus

@en

Primary cell model for activation-inducible human immunodeficiency virus

@nl

type

label

Primary cell model for activation-inducible human immunodeficiency virus

@en

Primary cell model for activation-inducible human immunodeficiency virus

@nl

prefLabel

Primary cell model for activation-inducible human immunodeficiency virus

@en

Primary cell model for activation-inducible human immunodeficiency virus

@nl

P1433

Q42093067-FD332859-2FB2-44BA-8D4F-BB4E284C9B10

P1476

Q42093067-7912D3E7-72CD-4213-9750-3CB7F433A3C7

P2093

Q42093067-3B49BB2D-A66D-4B0E-8365-EAD01CC744C6

Q42093067-4F4106F5-FA23-427D-A88F-54187F419C9B

Q42093067-520E777A-E251-4A03-B370-0AE285E210B3

Q42093067-5D5B12E1-DA0A-4971-A86C-65AD233657A8

Q42093067-6CBA7382-58E4-4348-9114-5090DD893BBE

Q42093067-E8D82A7A-9426-48B7-A208-DC47A82627C1

P2860

Q42093067-02029096-DF24-4210-9CD8-3A388D352351

Q42093067-044698C7-27FB-4006-9D12-0CE2116D8565

Q42093067-08A6245C-0D49-4E41-8DE2-80B7B5F98909

Q42093067-152B98F2-3C04-4E4C-8868-1E3E611A9084

Q42093067-23AC7180-E751-403E-BD8B-4B8F4D204460

Q42093067-24BAE78A-F3B7-42B3-8430-D90F62FDD500

Q42093067-24C85119-3CD9-4E78-939B-E9489B3FAD60

Q42093067-2E489C4E-5241-4FC0-AC80-AA3267BAFB91

Q42093067-2F38273B-DE3B-4F5B-B9EF-66F7CF9D65EC

Q42093067-349EE24F-A4A8-4305-940C-C6710CBAA9B8

P304

Q42093067-250CB816-5044-4833-85DC-C8DE18E34B42

P31

Q42093067-22763B4D-523F-4090-BD96-AB6611A2E25C

P356

Q42093067-5826D13A-DD3E-4B47-B85B-9A3462EFEE27

P407

Q42093067-B8D6E5DB-2BDA-46AE-BA2F-BEE7FEA4576B

P433

Q42093067-213EC9DE-48F8-48DD-B995-0ABD67A88285

P478

Q42093067-977FBF89-DE69-4FF6-B600-7203992791BE

P577

Q42093067-92FB1CAE-46AA-4617-849A-7BBAD79F52A3

P5875

Q42093067-F50B3D34-EC07-480C-848B-C0F698BFB1EA

P698

Q42093067-2540AF22-304A-43F7-9022-556054529CC4

P932

Q42093067-970D8486-FCAC-42D6-B96E-70440E302588

P356

P1433

Journal of Virology

P1476

Primary cell model for activation-inducible human immunodeficiency virus

@en

P2093

Bryan Burke

http://www.w3.org/2001/XMLSchema#string

Dimitrios N Vatakis

http://www.w3.org/2001/XMLSchema#string

Gregory Bristol

http://www.w3.org/2001/XMLSchema#string

Helen J Brown

http://www.w3.org/2001/XMLSchema#string

Jerome A Zack

http://www.w3.org/2001/XMLSchema#string

Matthew D Marsden

http://www.w3.org/2001/XMLSchema#string

P2860

Latent reservoirs of HIV: obstacles to the eradication of virus

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

The challenge of viral reservoirs in HIV-1 infection

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

P304

7424-7434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02838-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6353849

http://www.w3.org/2001/XMLSchema#string

P698

17475639

http://www.w3.org/2001/XMLSchema#string

P932

1933352

http://www.w3.org/2001/XMLSchema#string